Rhythm Pharmaceuticals to Present Virtually at Canaccord Genuity 40th Annual Growth Conference
BOSTON, Aug. 06, 2020 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a late-stage biopharmaceutical company aimed at developing and […]
Exela Technologies Launches its Electronic Signature Platform: DrySign
IRVING, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela”) (NASDAQ: XELA) today announced the launch of DrySign, […]
Gear4 Introduces Protective Cases for Samsung Galaxy Note20 5G and Note20 Ultra 5G
SALT LAKE CITY, Aug. 06, 2020 (GLOBE NEWSWIRE) — Gear4®, a ZAGG Brands (NASDAQ:ZAGG) company and the U.K.’s No. 1 […]
InvisibleShield Introduces Screen Protection for the Samsung Galaxy Note20 5G and Note20 Ultra 5G
SALT LAKE CITY, Aug. 06, 2020 (GLOBE NEWSWIRE) — InvisibleShield®, a ZAGG Brands (NASDAQ:ZAGG) company and the leading global innovator […]
TSX News -
Candente Copper Corp. Launches AGORACOM Online Marketing and Discussion Forum As Primary Investor Social Media Discussion Platform
VANCOUVER, British Columbia, Aug. 06, 2020 (GLOBE NEWSWIRE) — Candente Copper Corp. (TSX:DNT, BVL:DNT) (“Candente” or the “Company”) is pleased […]
Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2021 and Provides Business Update
U.S. COVID-19study showing positive safety profile for patients enrolled to dateBay Street News
Plug Power Announces 2020 Second Quarter Results
LATHAM, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a leading provider of hydrogen engines and fueling […]
ADT Announces Notes Offering
BOCA RATON, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) — ADT Inc. (NYSE: ADT) (the “Company” or “ADT”), a leading provider […]
InflaRx to Present at Upcoming Virtual Investor Events
JENA, Germany, Aug. 06, 2020 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by […]
Albireo Reports Q2 2020 Financial Results and Provides Business Update
— Completed last patient visits in Phase 3 PFIC and Phase 2 NASH Trials —— Enrolled first biliary atresia patients in […]
